This review summarises the latest evidence for the use of glutamine (GLN) in oncology taking cognisance of current systematic reviews and available guidelines. Various studies in adults suggest that GLN supplementation suppresses tumour growth. by restoring the function of natural killer cells; improves protein metabolism; and. possibly enhances the effect of cancer therapy. https://www.alarecre.com/